INS and metabolic disease: Muscle tissue accounts for 60%–70% of the insulin-stimulated glucose uptake and is described as a primary determinant of metabolic disorders (Montgomery et al., 2017; Mikovic and Lamon, 2018; Sun et al., 2020; Smits et al., 2022).